Drug-drug interactions in repeat prescriptions at village dispensaries (bereg) in Malta [PDF]
, 2013 Inappropriate treatments and drug-drug interactions (DDIs) are known to occur in settings where repeat prescriptions are issued. In view of this, a study was carried out to document any such problematic drug prescribing and propose changes that would
Bugeja, Anton
core
Role of Nucleoside Transport in Drug Action The Adenosine Deaminase Inhibitor, Deoxycoformycin, and the Antiplatelet Drugs, Dipyridamole and Dilazepa [PDF]
, 1985 Robert E. Parks +4 more
openalex +1 more source
The impact of antiplatelet drugs on recurrent stroke in patients with intracerebral hemorrhage. [PDF]
Heliyon, 2023 Wong YS, Tsai CF, Ong CT.
europepmc +1 more source
Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions. [PDF]
Biomolecules, 2023 Muravlev IA +6 more
europepmc +1 more source
Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer? [PDF]
, 2014 Mineok Chang, DukâWoo Park
openalex +1 more source
Acute Spontaneous Subdural Hematoma in a Patient With an End-Stage Renal Disease After Starting Dual Antiplatelet Therapy Post Drug-Eluting Stent Insertion: A Case Report [PDF]
, 2023 Aliaa Mousa +4 more
openalex +1 more source
Contemporary NSTEMI management: the role of the hospitalist. [PDF]
, 2019 Non-ST-segment elevation myocardial infarction (NSTEMI) is defined as elevated cardiac biomarkers of necrosis in the absence of persistent ST-segment elevation in the setting of anginal symptoms or other acute event.
Amin, Alpesh +9 more
core +1 more source
Antiplatelet drugs may increase the risk for checkpoint inhibitor-related pneumonitis in advanced cancer patients. [PDF]
ESMO Open, 2023 Araki T +12 more
europepmc +1 more source
Determinants of the interindividual variability in response to antiplatelet drugs [PDF]
, 2005 Bianca Rocca, Carlo Patrono
openalex +1 more source